{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:59:39Z","timestamp":1780077579277,"version":"3.54.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12928-021-00823-1","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T09:02:36Z","timestamp":1636794156000},"page":"549-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety and efficacy of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: a meta-analysis of in-hospital outcomes"],"prefix":"10.1007","volume":"37","author":[{"given":"Junichi","family":"Shimamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaqib","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,13]]},"reference":[{"issue":"22","key":"823_CR1","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.jacc.2018.08.2146","volume":"72","author":"TG Gleason","year":"2018","unstructured":"Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, et al. 5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018;72(22):2687\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"9986","key":"823_CR2","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","volume":"385","author":"SR Kapadia","year":"2015","unstructured":"Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485\u201391.","journal-title":"Lancet"},{"issue":"9","key":"823_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jacc.2020.12.052","volume":"77","author":"MB Leon","year":"2021","unstructured":"Leon MB, Mack MJ, Hahn RT, Thourani VH, Makkar R, Kodali SK, et al. Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk. J Am Coll Cardiol. 2021;77(9):1149\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"9986","key":"823_CR4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","volume":"385","author":"MJ Mack","year":"2015","unstructured":"Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477\u201384.","journal-title":"Lancet"},{"issue":"9","key":"823_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1910555","volume":"382","author":"RR Makkar","year":"2020","unstructured":"Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382(9):799\u2013809.","journal-title":"N Engl J Med"},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjcard.2021.01.023","volume":"146","author":"Y Ahmad","year":"2021","unstructured":"Ahmad Y, Howard JP. Meta-analysis of usefulness of cerebral embolic protection during transcatheter aortic valve implantation. Am J Cardiol. 2021;146:69\u201373.","journal-title":"Am J Cardiol"},{"issue":"5","key":"823_CR7","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/STROKEAHA.116.015915","volume":"48","author":"R Bagur","year":"2017","unstructured":"Bagur R, Solo K, Alghofaili S, Nombela-Franco L, Kwok CS, Hayman S, et al. Cerebral embolic protection devices during transcatheter aortic valve implantation: systematic review and meta-analysis. Stroke. 2017;48(5):1306\u201315.","journal-title":"Stroke"},{"key":"823_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008463)","author":"L Testa","year":"2018","unstructured":"Testa L, Latib A, Casenghi M, Gorla R, Colombo A, Bedogni F. Cerebral protection during transcatheter aortic valve implantation: an updated systematic review and meta-analysis. J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/JAHA.117.008463).","journal-title":"J Am Heart Assoc"},{"key":"823_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052874","author":"NM Butala","year":"2021","unstructured":"Butala NM, Makkar R, Secemsky EA, Gallup D, Marquis-Gravel G, Kosinski AS, et al. Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the TVT registry. Circulation. 2021. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052874.","journal-title":"Circulation"},{"key":"823_CR10","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"issue":"4","key":"823_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","volume":"66","author":"SY Kim","year":"2013","unstructured":"Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408\u201314.","journal-title":"J Clin Epidemiol"},{"key":"823_CR12","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"1","key":"823_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jtcvs.2012.09.002","volume":"145","author":"AP Kappetein","year":"2013","unstructured":"Kappetein AP, Head SJ, G\u00e9n\u00e9reux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145(1):6\u201323.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"823_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamainternmed.2019.6767","volume":"180","author":"M Alkhouli","year":"2020","unstructured":"Alkhouli M, Alqahtani F, Harris AH, Hohmann SF, Rihal CS. Early experience with cerebral embolic protection during transcatheter aortic valve replacement in the United States. JAMA Intern Med. 2020;180(5):783\u20134.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"823_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jama.2016.10302","volume":"316","author":"S Haussig","year":"2016","unstructured":"Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, L\u00fccke C, Woitek F, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA. 2016;316(6):592\u2013601.","journal-title":"JAMA"},{"issue":"4","key":"823_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","volume":"69","author":"SR Kapadia","year":"2017","unstructured":"Kapadia SR, Kodali S, Makkar R, Mehran R, Lazar RM, Zivadinov R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol. 2017;69(4):367\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"823_CR17","doi-asserted-by":"publisher","first-page":"e007605","DOI":"10.1161\/CIRCINTERVENTIONS.118.007605","volume":"12","author":"HG Kroon","year":"2019","unstructured":"Kroon HG, van der Werf HW, Hoeks SE, van Gils L, van den Berge FR, El Faquir N, et al. Early clinical impact of cerebral embolic protection in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2019;12(6):e007605.","journal-title":"Circ Cardiovasc Interv"},{"key":"823_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab213","author":"AJ Lansky","year":"2021","unstructured":"Lansky AJ, Makkar R, Nazif T, Mess\u00e9 S, Forrest J, Sharma R, et al. A randomized evaluation of the TriGuardTM HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial. Eur Heart J. 2021. https:\/\/doi.org\/10.1093\/eurheartj\/ehab213.","journal-title":"Eur Heart J"},{"issue":"18","key":"823_CR19","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jcin.2020.05.039","volume":"13","author":"M Megaly","year":"2020","unstructured":"Megaly M, Sorajja P, Cavalcante JL, Pershad A, G\u00f6ssl M, Abraham B, et al. Ischemic stroke with cerebral protection system during transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2020;13(18):2149\u201355.","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"823_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcin.2020.11.011","volume":"14","author":"TM Nazif","year":"2021","unstructured":"Nazif TM, Moses J, Sharma R, Dhoble A, Rovin J, Brown D, et al. Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II. JACC Cardiovasc Interv. 2021;14(5):515\u201327.","journal-title":"JACC Cardiovasc Interv"},{"issue":"22","key":"823_CR21","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.jcin.2017.06.037","volume":"10","author":"J Seeger","year":"2017","unstructured":"Seeger J, Gonska B, Otto M, Rottbauer W, W\u00f6hrle J. Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures. JACC Cardiovasc Interv. 2017;10(22):2297\u2013303.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"823_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4244\/EIJV12I4A84","volume":"12","author":"NM Van Mieghem","year":"2016","unstructured":"Van Mieghem NM, van Gils L, Ahmad H, van Kesteren F, van der Werf HW, Brueren G, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention. 2016;12(4):499\u2013507.","journal-title":"EuroIntervention"},{"key":"823_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.05.010","author":"F Yashima","year":"2021","unstructured":"Yashima F, Briasoulis A, Kuno T, Noguchi M, Ahmad H, Zaid S, et al. Cerebral embolic protection during transcatheter aortic valve replacement. Cardiovasc Revasc Med. 2021. https:\/\/doi.org\/10.1016\/j.carrev.2021.05.010.","journal-title":"Cardiovasc Revasc Med"},{"issue":"2","key":"823_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcin.2020.09.047","volume":"14","author":"P Stachon","year":"2021","unstructured":"Stachon P, Kaier K, Heidt T, Wolf D, Duerschmied D, Staudacher D, et al. The use and outcomes of cerebral protection devices for patients undergoing transfemoral transcatheter aortic valve replacement in clinical practice. JACC Cardiovasc Interv. 2021;14(2):161\u20138.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-021-00823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-021-00823-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-021-00823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T10:44:56Z","timestamp":1655203496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-021-00823-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,13]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1007\/s12928-021-00823-1","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,13]]},"assertion":[{"value":"17 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}